We report the optimization of a series of non-steroidal GR antagonists that led to the identification of compound 7. This compound is efficacious when dosed orally in an olanzapine-induced weight gain model in rats.
Shahadat Ahmed合作论文数1george hynd合作论文数1Steve Daly合作论文数1Elizabeth O'Connor合作论文数1Mohammed Sajad合作论文数1Gerry Buckley合作论文数1Nick Ray合作论文数1Hazel Hunt合作论文数1Belanoff Joe合作论文数1Robin CLARK合作论文数Met Office1Peter M. Lockey合作论文数1
Christine Blasey合作论文数Department of Psychiatry and Behavioral Sciences, School of Medicine, Stanford University1Robert L. Roe合作论文数1
